PSI WEB
search
search

elearning

events

recruitment

careers centre

search members

 

Login Required

Access to Pharmaceutical Statistics content is one of the benefits of PSI membership.  To access the journal you must be logged in, please enter your log in details below and click the Sign In button.
Please note that once you have signed in you will be directed to the PSI website members area.  The Pharmaceutical Statistics website should open in a new window, you may have to allow your browser to open pop-up windows for this to work

  
 
Username Password
Remember Me
   
Forgotten Password? Click Here
Pharmaceutical Statistics RSS Feed:
Pharmaceutical Statistics
Wiley InterScience : Pharmaceutical Statistics
Intent-to-treat analysis in the presence of off-treatment or missing data
02 Mar 2010, 05:03:00 | Oliver N. Keene
Intent-to-treat (ITT) analysis is viewed as the analysis of a clinical trial that provides the least bias, but difficult issues can arise. Common analysis methods such as mixed-effects and proportional hazards models are usually labeled as ITT analysis, but in practice they can often be inconsistent with a strict interpretation of the ITT principle. In trials where effective medications are available to patients withdrawing from treatment, ITT analysis can mask important therapeutic effects of the intervention studied in the trial. Analysis of on-treatment data may be subject to bias, but can address efficacy objectives when combined with careful review of the pattern of withdrawals across treatments particularly for those patients withdrawing due to lack of efficacy and adverse events. Copyright © 2010 John Wiley & Sons, Ltd.
web design by adshires.co.uk